Corbus Pharmaceuticals Holdings Inc (CRBP)
17.86
-0.12
(-0.67%)
USD |
NASDAQ |
Nov 27, 15:45
Corbus Pharmaceuticals Holdings Total Liabilities (Quarterly): 13.67M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.67M |
| June 30, 2024 | 26.44M |
| March 31, 2024 | 28.78M |
| December 31, 2023 | 35.18M |
| September 30, 2023 | 35.97M |
| June 30, 2023 | 34.20M |
| March 31, 2023 | 35.19M |
| December 31, 2022 | 33.32M |
| September 30, 2022 | 31.88M |
| June 30, 2022 | 32.60M |
| March 31, 2022 | 34.52M |
| December 31, 2021 | 38.62M |
| September 30, 2021 | 41.95M |
| June 30, 2021 | 43.65M |
| March 31, 2021 | 48.63M |
| December 31, 2020 | 57.02M |
| September 30, 2020 | 66.61M |
| June 30, 2020 | 49.70M |
| March 31, 2020 | 42.51M |
| December 31, 2019 | 42.98M |
| September 30, 2019 | 38.49M |
| Date | Value |
|---|---|
| June 30, 2019 | 36.75M |
| March 31, 2019 | 59.09M |
| December 31, 2018 | 19.47M |
| September 30, 2018 | 18.31M |
| June 30, 2018 | 14.80M |
| March 31, 2018 | 11.60M |
| December 31, 2017 | 9.195M |
| September 30, 2017 | 6.439M |
| June 30, 2017 | 6.975M |
| March 31, 2017 | 7.021M |
| December 31, 2016 | 8.969M |
| September 30, 2016 | 6.443M |
| June 30, 2016 | 4.974M |
| March 31, 2016 | 4.091M |
| December 31, 2015 | 3.890M |
| September 30, 2015 | 2.16M |
| June 30, 2015 | 2.796M |
| March 31, 2015 | 0.5548M |
| December 31, 2014 | 0.738M |
| September 30, 2014 | 0.6137M |
| December 31, 2013 | 2.089M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.67M
Minimum
Sep 2024
66.61M
Maximum
Sep 2020
38.67M
Average
35.58M
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Electromed Inc | 7.427M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 164.17M |
| Shareholders Equity (Quarterly) | 150.50M |